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Background and aim: Leptin, a hormone mainly produced by fat cells, acts primarily on the hypotha-
lamus regulating energy expenditure and food intake. Leptin receptors are expressed in several tissues
and the possible physiological role of leptin is being extensively investigated, with the result that impor-
tant peripheral actions of the hormone in the organism are being discovered. Recent studies have dem-
onstrated leptin and leptin receptor expression in gastric epithelial cells. In the present study, we report
the presence of the long leptin receptor isoform (OB-Rb) in human, rat, and mouse small intestine, sup-
porting the hypothesis of leptin as a hormone involved in gastrointestinal function.
Methods: The presence of the leptin receptor was determined by immunocytochemical methods using
antibodies against the peptide corresponding to the carboxy terminus of the long isoform of the leptin
receptor. Human duodenal biopsies from normal individuals undergoing gastrointestinal endoscopy,
and intestinal fragments of Wistar rats and Swiss mice were processed for the study.
Results: Immunoreactivity for the long leptin receptor isoform was observed in the three studied spe-
cies. Staining was located throughout the cytoplasm of the enterocytes, of both villi and crypts, and in
the basolateral plasma membrane. Immunolabelling for OB-Rb protein was also found in the brush bor-
der of human enterocytes of formol and paraformaldehyde fixed samples.
Conclusion: This report demonstrates the presence of the long leptin receptor isoform in the absorptive
cells of rat, mouse, and human small intestine, suggesting that leptin could have a physiological role in
the regulation of nutrient absorption.
Leptin is a 16 kDa hormone mainly produced by fat cells
1 that
regulates food intake and energy expenditure by providing
afferent signals to the hypothalamus.2–4 Its expression and
secretion are highly correlated with body fat mass and
adipocyte size, and regulated by different factors such as hor-
mones, nutritional state, and the sympathetic nervous
system.5–7 Leptin has structural similarities to certain cyto-
kines and its receptor, the OB-R protein cloned from brain,8 is
a member of the cytokine class I receptor superfamily.
There are several OB-R isoforms which are splicing variants
of a single gene transcript.9–11 Identical regions in all receptor
isoforms include an extracellular domain, a transmembrane
domain, and the first 29 amino acids of the cytoplasmic domain.
According to the length of the intracellular domain, there is one
long isoform (OB-Rb) and four short isoforms (OB-Ra, c, d, f),
which differ in their cytosolic carboxy terminus. Finally, there is
one soluble isoform (OB-Re) which lacks the transmembrane
domain and may be involved in leptin transport in the blood.
When leptin binds to the OB-Rb receptor, it activates JAK/STAT
(Janus kinase/signal transducer and activator of transcription)
and MAPK (mitogen activated protein kinase) signal transduc-
tion pathways in a variety of in vitro systems.12
Apart from the original tissues from which leptin and its
receptor were cloned, expression of both proteins has also
been found in many other tissues,13–17 which demonstrates
possible important peripheral actions in rodents and
humans.18–20 Recent data suggest that leptin could also be con-
sidered a gastrointestinal hormone. Leptin mRNA and protein
have been found in fundic epithelium of rat stomach,14 and in
humans not only leptin but also its receptor is expressed in
gastric epithelial cells.15 21 In mouse small intestine, the
presence of OB-Rb has been reported using reverse
transcription-polymerase chain reaction (RT-PCR) and west-
ern blot analysis, and intravenous administration of leptin
reduces jejunal apolipoprotein AIV mRNA levels.22 Moreover,
functional studies from our laboratory have shown that leptin
decreases sugar uptake by rat small intestine in vitro.23
Following on from our previous studies, the present report
documents the immunocytochemical localisation of the long
leptin receptor isoform in human, rat, and mouse enterocytes.
This is the first time that the presence of the leptin receptor
protein in mammalian enterocytes has been reported.
MATERIAL AND METHODS
Subjects
Patients (n=10) undergoing upper gastrointestinal endoscopy
at the Hospital of the University of Navarra were used with the
approval of the ethics committee. All patients included in this
study had normal duodenal mucosa. For the immunohisto-
chemical study, two or three duodenal biopsy samples were
obtained from each patient and fixed in 10% formol, Bouin’s,
or 4% paraformaldehyde (PAF) fixatives before paraffin
embedding. In addition, some PAF fixed samples were frozen
and used for cryostat sectioning.
Wistar rats (200–250 g; n=4) and Swiss mice (100–110 g;
n=2), after a 24 or 12 hour fast, respectively, were killed by cer-
vical dislocation and a jejunum segment of 20 cm and 10 cm,
respectively, was quickly excised and rinsed in ice cold saline
solution. The segment was cut into small pieces (1–2 cm) which
were fixed in Bouin’s or formol fixatives for immunohisto-
chemical investigation. After 24 hours of fixation at room tem-
perature, samples were dehydrated and embedded in paraffin.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Abbreviations: OB-Rb, long leptin receptor isoform; BBPM, brush
border plasma membrane; BLPM, basolateral plasma membrane; RT-PCR,
reverse transcription-polymerase chain reaction; PAF, paraformaldehyde.
See end of article for
authors’ affiliations
. . . . . . . . . . . . . . . . . . . . . . .
Correspondence to:
M P Lostao, Department of
Physiology and Nutrition,
Irunlarrea s/n, Pamplona
31008, Spain;
plostao@unav.es
Accepted for publication
7 August 2001
. . . . . . . . . . . . . . . . . . . . . . .
797
www.gutjnl.com
 group.bmj.com on February 28, 2012 - Published by gut.bmj.comDownloaded from 
Rat jejunum was also processed for resin embedding using
a perfusion/fixation method.24 The fixative composition was:
4% PAF, 0.1% glutaraldehyde, and 0.2% saturated picric acid in
0.125 M phosphate buffer, pH 7.4. After fixation, the jejunum
was cut into 1 mm pieces, dehydrated, embedded in epon, and
sliced into 1 µm thick sections.
Immunohistochemical procedure
Sections (3 µm thick) were cut and mounted on glass slides.
After dewaxing with xylene, immunocytochemical staining
was performed using the streptavidin-biotin method. Sections
were hydrated through alcohols, and endogenous peroxidase
was blocked by treatment with 3% H2O2 for 10 minutes in the
dark and afterwards placed in phosphate buffered saline (65
mM NaCl, 1.05 mM KCl, 4.05 mM Na2HPO4, 0.5 mM KH2PO4,
pH 7.4).
Non-specific background was blocked with 2% normal swine
or rabbit serum for 30 minutes and sections were incubated
overnight at 4°C with the primary antibody. After incubation
with biotinylated link antibody (swine antirabbit Dako E0353,
Figure 1 Intracytoplasmic immunolabelling for the long leptin receptor isoform (OB-Rb) (A, B: human duodenum, Bouin’s fixation; C-G: mouse
jejunum, formol fixation). (A) Immunostaining for OB-Rb (*) was found throughout the cytoplasm of human enterocytes. Labelling was absent
from the brush border (short arrows). White arrow, Goblet cell. Occasional unstained—perhaps endocrine—cells (black arrow) may also
occur. (B) Absorption test in human tissue: immunolabelling was abolished using preabsorbed antiserum. (C, D) Immunolabelling for the leptin
receptor (*) was present in both the basal and apical cytoplasm of mouse enterocytes. In contrast, the brush border was not immunostained
(short arrow). Labelling was observed in both villi (C) and crypts (D). Immunostaining was observed in all enterocytes lining intestinal villi and
crypts. White arrow, Goblet cell; black arrow, Paneth cell. (E, F) Panoramic micrograph of two intestinal villi (E) and detailed enterocytes (F).
Intracytoplasmic immunolabelling for OB-Rb, although extended throughout the cell, was stronger in the apical cytoplasm underlying the brush
border (*). Nickel enhancement method. (G) Absorption test in mouse tissue: no immunostaining was obtained. A–D, F, G: bars=14 µm; E:
bar=35 µm.
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rabbit antigoat Dako E466) for one hour and peroxidase labelled
streptavidin for another hour, both at a working dilution of
1:200, bound antibodies were visualised by immersion treat-
ment of the sections with 0.25% 3′,3′- diaminobenzidine
tetrahydrochloride used as chromogen in 0.05 M Tris-HCl
buffer, pH 7.36, with 0.5% H2O2 for 30 seconds. Sections were
then rinsed in tap water, counterstained with haematoxylin,
dehydrated, and mounted with DPX. For semithin (1 µm)
section immunostaining, epon was removed with aged satu-
rated sodium hydroxide in ethanol for one hour. The incubation
time for the primary antibody was prolonged to 48 hours, at 4°C,
and the biotinylated antibody and streptavidine peroxidase
complexes were used at a 1:100 working dilution. In some cases,
the reaction was intensified by means of 0.03% diaminobenzi-
dine tetrahydrochloride in 0.1 M sodium acetate/acetic acid, pH
5.6, containing 2.5% ammonium nickel sulphate, 0.2% β-D-
glucose, 0.04% ammonium chloride, and 0.01% glucose oxidase.
Two different antibodies were used: human leptin receptor
goat polyclonal antibody (C-20; Santa Cruz Biotechnology
Inc., Santa Cruz, California, USA) at a working dilution of 1:50
was used for human intestine samples, and rat leptin receptor
rabbit polyclonal antibody (OBR13; Alpha Diagnostics Inter-
national, Inc. San Antonio, Texas, USA) at a dilution of 1:200,
was used for both the rat and mouse samples. Antibodies were
raised against the peptides corresponding to amino acids
1146–1165 (C-20) and 1145–1162 (OBR13) mapping the car-
boxy terminus of the full length leptin receptor, and therefore
were specific for the long receptor isoform (OB-Rb). Antibody
OBR13, specific for rat and mouse receptor, did not cross react
with human tissue samples. Microwave pretreatment im-
proved immunolabelling for the two fixatives in the three spe-
cies but did not change the distribution pattern. Pretreated
sections were unmasked by heat in 10 mM sodium citrate
buffer (pH 6) for two periods of 15 minutes.
Absorption controls were performed to test the specificity of
immunostaining. Antisera to leptin receptor were preincu-
bated with 10-fold excess of homologous peptide at 4°C over-
night before application to tissue sections. For all antibodies,
Figure 2 Immunostaining for the long leptin receptor isoform in the brush border of human enterocytes: formol fixed, paraffin embedded
samples (A, B); paraformaldehyde (PAF) fixed, paraffin embedded samples (C, D); PAF fixed, cryostat sections (E, F). The brush border
displayed immunostaining in the enterocytes of both intestinal villi (A, C–E) and crypts (B). The striated appearance of the brush border was
evident (arrows). Immunostaining for the leptin receptor (E) was absent using preabsorbed antiserum (F). A, D: bars=14 µm; B, C, E, F:
bars=35 µm.
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preabsorption of the antiserum with the peptide abolished
immunoreaction. Immunolabelling was also absent when the
primary antibody was omitted.
To check if the human antibody showed cross reactivity
with any other similar peptide antigen, a computer search was
performed using the Protein BLAST database. The results
showed that the peptide recognised by the human C-20 anti-
body only aligns with the carboxy terminus of the human
OB-Rb receptor (100% identity) and with the rat and mouse
OB-Rb receptor (95% identity). The alignment with cytokine
receptors showed 0% homology. Likewise, the peptide
recognised by the rat OBR13 antibody also aligns with the
mouse (99% identity) and human (94% identity) OB-Rb
receptor. These results indicate that both antibodies are
specific for the long leptin receptor isoform. Furthermore, the
C-20 antibody has been extensively used in other papers to
show immunolocalisation of the long leptin receptor isoform
in different tissues.21
In initial experiments, two other polyclonal antibodies were
used and found to be positive in rat and mouse tissue samples.
Both antibodies were goat antileptin receptor raised, respec-
tively, against the carboxy terminal fragment 877–894 and the
amino terminal fragment 32–51 of the leptin receptor of
mouse origin (Research Diagnostics Inc. Flanders, New Jersey,
USA). However, such antibodies recognise all receptor isofoms
and therefore did not discriminate between the short and long
receptor isoforms.
RT-PCR procedure
Total RNA was isolated from 24 human duodenal mucosa
samples using TriPure Isolation Reagent (Boehringer Man-
nheim, Germany). First strand cDNA was generated using 4
µg RNA and M-MLV reverse transcriptase (Gibco BRL, Life
Technologies, Barcelona, Spain). To detect OB-Rb mRNA
expression, we used the primers and PCR conditions
previously described for human fundic biopsy samples.21 In
addition, the identity of the PCR product was confirmed by
sequencing.
RESULTS
Immunoreactivity for the long isoform of the leptin receptor
was found in the enterocytes of the three studied species
(human, rat, and mouse). In all cases, immunostaining was
located in the cytoplasm and basolateral plasma membrane
(BLPM) of the absorptive cells. In addition, human entero-
cytes also displayed immunolabelling in the brush border.
Several immunohistochemical processing methods were
needed to demonstrate the different locations of the
immunolabelling.
Immunostaining for the leptin receptor was present within
the cytoplasm of human (fig 1A), mouse (fig 1C–F), and rat
enterocytes. Labelling was usually observed extended
throughout the cell, both in the apical and basal cytoplasm.
Staining was often more intense in the apical cytoplasmic
region underlying the brush border (fig 1E, F). Intracytoplas-
mic staining was observed in enterocytes lining both the
intestinal villi (fig 1A, C, E) and crypts (fig 1D). Although villi
staining was always found, in some samples crypt staining
was weaker or absent. Preabsorption tests demonstrated the
specificity of the staining (fig 1B, G).
Cytoplasmic labelling of human enterocytes was always
achieved in samples fixed in Bouin’s but not in the other fixa-
tives (figs 2, 3). Mouse and rat enterocytes showed the same
intracytoplasmic labelling pattern using either fixative as well
as two other antibodies apart from OBR13. While confirming
the presence of the leptin receptor, these antibodies (as
indicated in the methods section) cannot distinguish between
the short and long receptor isoforms.
Immunostaining for the leptin receptor was also found in
the brush border plasma membrane (BBPM) of human enter-
ocytes in formol (figs 2A, B, 3) and PAF (fig 2C–F) fixed sam-
ples. As with intracytoplasmic labelling, stained brush border
was observed in both intestinal villi (figs 2A, C, E, 3A) and
crypts (fig 2B). Preabsorption tests also demonstrated the
specificity of the staining (figs 2E, F, 3).
In the BLPM, brown staining was often observed in Bouin’s
fixed human biopsies and rat and mouse intestine, especially
when the nickel enhancement revealing method was used (fig
4A, B) but disappeared when preabsorbed antiserum was used
(fig 4C). Given the difficulty in ascertaining immunolabelling
of BLPM staining, a third processing method was also used in
rodents. When rat specific antibody, OBR13, was applied to
1 µm sections of epon embedded rat intestine, immunolabel-
ling of BLPM was clearly found (fig 4D, E).
Expression of mRNA encoding for OB-Rb protein was
detected in human duodenal mucosa, further supporting the
presence of the long leptin receptor isoform in human entero-
cytes (fig 5)
DISCUSSION
In this study, we demonstrated the presence of the long leptin
receptor isoform (OB-Rb) in human and murine small intes-
tine using immunocytochemical techniques. In the case of
human tissue, RT-PCR confirmed the presence of OB-Rb.
Given that achievement of immunolabelling in immunocy-
tochemical studies frequently depends on the histological
processing of the samples, we used different processing meth-
ods. As a result, immunolabelling was obtained in the brush
border, cytoplasm, and basolateral membrane of enterocytes.
While many studies have examined the effect of leptin on
hypothalamic neurones involved in regulating food intake and
energy metabolism, not much is known about the action of
leptin in the small intestine. Recent reports have demon-
strated a possible role for leptin in intestinal lipid handling22
Figure 3 Preabsorption tests demonstrated the specificity of
immunostaining for the long leptin receptor in the brush border
plasma membrane of formol fixed human intestine. Incubation of
antiserum with the antigen (B) abolished immunostaining of the brush
border (A). Note that brush border plasma membrane
immunolabelling occurred in all enterocytes. Bars=40 µm.
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and sugar absorption23 25 and the presence of leptin receptors
in mouse intestine and Caco-2 cells by biochemical
methods.22 Moreover, studies on 125I-leptin tissue distribution
have shown that the small intestine of the rat and mouse con-
tains the highest concentration of the hormone.26 27 Also, OB-R
mRNA expression has been found in the intestine of juvenile
and sexually matured hens, and oestrogen treatment was
found to enhance OB-R mRNA expression in the intestine.28
Intracellular immunostaining of OB-Rb found in entero-
cytes is in agreement with the subcellular localisation of lep-
tin receptors in other tissues. For example, using antibodies
which do not discriminate between the different receptor iso-
forms, the immunostaining pattern in human brain showed a
granular appearance within the cytoplasm, with an intense
peripheral cytoplasmic rim.29 In mouse brain, ultrastructural
immunocytochemistry shows that the staining concentrates
at the level of the neuronal Golgi complex.30 Ultrastructural
localisation of OB-Rb in human white adipose tissue again
reveals the strongest expression in the cytoplasm rim31 and
finally, confocal immunofluorescence microscopy in endothe-
lial cells showed a strong signal for OB-Rb characterised by
scattered punctuate intracellular staining.32 In COS-7 cells
transfected with the cDNA of the human long and short
receptor isoforms, immunofluorescence showed intense peri-
nuclear staining in the cytoplasm.33
In the case of enterocytes, we do not know whether
intracellular immunostaining corresponds to internalised
receptor after leptin binding, recycling of the receptor, or the
biosynthetic pathway compartments, including trafficking of
Figure 4 Immunostaining of the basolateral plasma membrane (BLPM) of enterocytes for the long leptin receptor isoform. (A-C: human
duodenum, Bouin’s fixation; D, E: rat jejunum, epon embedded). BLPM immunostaining for the leptin receptor (arrows) was observed in human
enterocytes in both longitudinal (A) and cross/oblique (B) sections of the epithelium. (C) Immunolabelling of the BLPM disappeared with
preabsorption of the antiserum. (D, E) In (D), immunolabelling of the BLPM was evident (arrows). Note that labelling was not present in the most
apical lateral regions of cells where junctional complexes are known to exist in the plasma membrane. For this reason a “loop” can be
observed systematically in the labelling (curved arrows). In preabsorbed sections (*, E), immunolabelling of the BLPM disappeared. Staining of
the lamina propria (*, D) was not specific as it did not disappear after absorption of antiserum (E). Stars, widened intercellular basolateral
spaces. Bars=14 µm.
Figure 5 Reverse
transcription-polymerase chain
reaction detection of long leptin
receptor isoform (Ob-Rb) mRNA
from human duodenum. Lane 1,
100 base pair DNA ladder; lane
2, OB-Rb (expected size 238
bp); lane 3, reverse transcriptase
omission.
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newly formed vesicles containing the receptor, as has been
shown in COS-7 cells transfected with the leptin receptor.34
Nevertheless, all of the immunocytochemical studies reported
that the majority of the receptor, short or long isoform, was
located in the intracellular compartments29–34 and with some
degree of polarity (that is, more intense immunostaining) at
the apical surface, as in brain ependymal cells29 and our enter-
ocytes.
Specific immunoreaction was also found in the BLPM of
enterocytes. This location of the receptor is what we would
expect, considering that leptin reaches the intestinal epithe-
lium from the blood. The fact that this label was not apparent
in all preparations could be due to the intensity of the
intracellular labelling that would mask basolateral staining, or
to a cyclical absence of the receptor in the BLPM, reflecting the
physiological status of the individual.
Surprisingly, labelling was also found in the BBPM of
human enterocytes. Immunostaining seems certain as it was
found with three different histological processing methods
and control absorption demonstrated its specificity.
Why is the leptin receptor present in the BBPM if leptin
must reach the enterocytes from blood? It has been
demonstrated that rat and human stomach mucosa stores and
secretes leptin.14 21 More accurately, apart from endocrine cells,
secretory granules of chief cells of the human gastric mucosa
contain leptin.15 Furthermore, infusion of secretin or penta-
gastrin in normal individuals increases leptin output both in
gastric juice and in plasma.21 As these authors have also found
OB-Rb protein in the BLPM of gastric cells, they suggest a
paracrine/autocrine role of leptin in the stomach, probably
related to control of feeding behaviour.14 15 Given this finding,
we may also think of leptin reaching not only the basolateral
side of the enterocytes but also the brush border, binding to its
receptor and regulating sugar transport and lipid
handling.22 23 25 In fact, intracytoplasmic staining is frequently
stronger in the apical cytoplasm of enterocytes, which could
reflect more intense trafficking of leptin receptor bearing vesi-
cles.
In summary, we have demonstrated the presence of the long
leptin receptor isoform in human, rat, and mouse enterocytes
which supports consideration of leptin as a new hormone
involved in the regulation of gastrointestinal tract function.
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